Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Dermatol Venereol Leprol ; 2007 Jul-Aug; 73(4): 280
Article Dans Anglais | IMSEAR | ID: sea-52162

Résumé

BACKGROUND: Intralesional sodium stibogluconate (SSG) has become first line therapy for localized cutaneous leishmaniasis (LCL). AIMS: This study compares the efficacy of intralesional SSG given alone with that of intralesional SSG combined with intramuscular SSG. METHODS: Thirty-two patients aged between 5-56 years were included in the study. The first group received three injections of intralesional SSG on alternate days while the other group received three injections of intralesional SSG similar to the first group and the rest of the calculated dose as a simultaneous, intramuscular injection. Patients were followed up every four weeks to assess for cure/ the need for repeating the treatment. RESULTS: Five patients from group 1 having small nodular lesions of < six months duration were cured after 1-2 treatment cycles. However, six patients with mucosal lesions, large lesions and lesions of > six months duration needed 3-5 treatment schedules. Most plaques and mucosal lesions in seven patients in group 2 cleared with two treatment cycles. CONCLUSION: Intralesional combined with intramuscular SSG appears more effective in LCL and gave qualitatively superior healing than intralesional SSG given alone.


Sujets)
Adolescent , Adulte , Gluconate d'antimoine et de sodium/administration et posologie , Antiprotozoaires/administration et posologie , Enfant , Enfant d'âge préscolaire , Calendrier d'administration des médicaments , Femelle , Humains , Injections intralésionnelles , Injections musculaires , Leishmaniose cutanée/traitement médicamenteux , Mâle , Adulte d'âge moyen , Projets pilotes , Peau/parasitologie , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche